Sansure Biotech Inc., a leading molecular diagnostics specialist based in China (SHA: 688289), has announced that it has received CE marks for 60 of its products, including a procalcitonin assay kit that utilizes chemiluminescent immunoassay technology. This significant milestone underscores the company’s commitment to expanding its global footprint and enhancing diagnostic capabilities.
Product Range and Applications
The range of products that have earned CE marks spans across various critical areas of medical diagnostics. These include assays for myocardial markers, inflammation, tumor markers, thyroid function, sex hormones, glucose metabolism, and growth and development, among others. This comprehensive product portfolio addresses a wide array of healthcare needs, providing medical professionals with essential tools for accurate diagnosis and patient care.
Surelite Chemiluminescence Product Series
Sansure Biotech has launched its Surelite series, which is known for its high sensitivity, accuracy, and stable measurement values in chemiluminescence assays. The series is designed to cater to the needs of small and medium-sized hospitals in the international market, which often handle smaller sample sizes but require precision and tiered healthcare services. The high degree of automation in the Surelite series ensures efficiency and reliability, making it an attractive option for laboratories seeking to enhance their diagnostic capabilities.
Conclusion
The receipt of CE marks for Sansure Biotech’s 60 products, including the procalcitonin assay kit, is a testament to the company’s dedication to innovation and quality in molecular diagnostics. As the company continues to expand its product offerings and gain international recognition, it is well-positioned to contribute to the advancement of diagnostic medicine worldwide.-Fineline Info & Tech
